Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease. | Rev Endocr Metab Disord | 2023 | 37000372 | PubTator, text mining | PubMed |
| MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway. | Cancer Med | 2023 | 36999945 | PubTator, text mining | PubMed |
| Kaempferol, a Phytoprogestin, Induces a Subset of Progesterone-Regulated Genes in the Uterus. | Nutrients | 2023 | 36986136 | PubTator, text mining | PubMed |
| Iroquois Family Genes in Gastric Carcinogenesis: A Comprehensive Review. | Genes (Basel) | 2023 | 36980893 | PubTator, text mining | PubMed |
| The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. | Cancers (Basel) | 2023 | 36980527 | PubTator, text mining | PubMed |
| Heterogeneity of Cholangiocarcinoma Immune Biology. | Cells | 2023 | 36980187 | PubTator, text mining | PubMed |
| Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. | J Transl Med | 2023 | 36973787 | PubTator, text mining | PubMed |
| Specific regulation of BACH1 by the hotspot mutant p53R175H reveals a distinct gain-of-function mechanism. | Nat Cancer | 2023 | 36973430 | PubTator, text mining | PubMed |
| HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. | Cell Death Dis | 2023 | 36973255 | PubTator, text mining | PubMed |
| Comprehensive bioinformatic analysis constructs a CXCL model for predicting survival and immunotherapy effectiveness in ovarian cancer. | Front Pharmacol | 2023 | 36969851 | PubTator, text mining | PubMed |
| A three protein signature fails to externally validate as a biomarker to predict surgical outcome in high-grade epithelial ovarian cancer. | PLoS One | 2023 | 36952534 | PubTator, text mining | PubMed |
| Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis. | Front Oncol | 2023 | 36950551 | PubTator, text mining | PubMed |
| Meteorin-like levels are associated with active brown adipose tissue in early infancy. | Front Endocrinol (Lausanne) | 2023 | 36936161 | PubTator, text mining | PubMed |
| CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors. | Sci Rep | 2023 | 36928082 | PubTator, text mining | PubMed |
| Single-cell transcriptome reveals Staphylococcus aureus modulating fibroblast differentiation in the bone-implant interface. | Mol Med | 2023 | 36927352 | PubTator, text mining | PubMed |
| An integrated single cell and spatial transcriptomic map of human white adipose tissue. | Nat Commun | 2023 | 36922516 | PubTator, text mining | PubMed |
| Extracellular matrix-based gene signature for predicting prognosis in colon cancer and immune microenvironment. | Transl Cancer Res | 2023 | 36915600 | PubTator, text mining | PubMed |
| Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. | Cancers (Basel) | 2023 | 36900213 | PubTator, text mining | PubMed |
| lncRNA-TCONS_00008552 expression in patients with pulmonary arterial hypertension due to congenital heart disease. | PLoS One | 2023 | 36893166 | PubTator, text mining | PubMed |
| De-novo reconstruction and identification of transcriptional gene regulatory network modules differentiating single-cell clusters. | NAR Genom Bioinform | 2023 | 36879901 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers?page=26